Search

everythinglearnresearchcommunity

for

Search:↓

Metreleptin treatment significantly improved metabolic health in a boy with congenital generalized lipodystrophy.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

A clinical nutrition program improved sensory and motor function in a 60-year-old with anti-MAG neuropathy.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

A woman with severe hair loss was successfully treated with the drug adalimumab.

A dissolving microneedle patch with dutasteride offers effective, long-lasting hair loss treatment with fewer side effects.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Pranlukast and mirabegron may work as new diabetes drugs.

Metformin and liraglutide improved symptoms of HAIR-AN syndrome in a child.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

A woman with acromegaly experienced severe hair loss from a drug called Lanreotide Autogel, which improved after stopping the treatment.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Guselkumab effectively reduces fatigue in Psoriatic Arthritis patients over two years.

The new cream with N-acetyl glucosamine didn't change skin color after 8 weeks.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

Modified laparoscopic sleeve gastrectomy effectively controls diabetes and treats obesity with minimal complications.

Adipose stem cell exosomes can effectively reduce facial redness and improve skin health in atopic dermatitis patients.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Microneedle-delivered polyglutamate effectively and safely improves hair growth in androgenetic alopecia.